<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Tel-Hai skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Tel-Hai</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="pageContainer"><HEADER><NAV><UL id="menu-nav"><LI><A href="https://2016.igem.org/Team:Tel-Hai">Home</A></LI><LI><A href="#">Team</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/AboutUs">About Us</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Attributions">Attributions</A></LI></UL><LI><A href="#">Project</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Description">Description</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Design">Applied Design</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Proof">Proof of Concept</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Achievements">Achievements</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Entrepreneurship">Entrepreneurship</A></LI><LI><A href="#">Human Practice</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Integrated_Practice">Human Practice</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/HP/Silver">HP Silver &amp; Gold</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Engagement">Public Engagement</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Ethics">Ethics</A></LI><LI><A href="#">Lab Work</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Notebook">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Methodolodogy">Methodolodogy</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Protocols">Protocols</A></LI><LI><A href="https://2016.igem.org/Team:Tel-Hai/Parts">Our Parts</A></LI></NAV><H2><SPAN>i</SPAN>GEM Tel-Hai 2016</H2></HEADER><DIV class="space-equally"><DIV class="flip-container" ontouchstart="this.classList.toggle('hover');"><DIV class="flipper"><DIV class="front"><H3><SPAN>Where</SPAN> is the magic happening?</H3></DIV><DIV class="back"><P>Tel-Hai and MIGAL's labs located in northen Israel</P></DIV></DIV></DIV><DIV class="flip-container" ontouchstart="this.classList.toggle('hover');"><DIV class="flipper"><DIV class="front"><H3><SPAN>Who</SPAN> are we?</H3></DIV><DIV class="back"><P>Group of dedicated students and researchers from the fields of biotechnology and biochemistry</P></DIV></DIV></DIV><DIV class="flip-container" ontouchstart="this.classList.toggle('hover');"><DIV class="flipper"><DIV class="front"><H3><SPAN>What</SPAN> is our goal?</H3></DIV><DIV class="back"><P>Correcting the most prevalent mutation in the CFTR protein, causing Cystic Fibrosis, in somatic cells</P></DIV></DIV></DIV><DIV class="flip-container" ontouchstart="this.classList.toggle('hover');"><DIV class="flipper"><DIV class="front"><H3><SPAN>Why</SPAN> did we choose Cystic Fibrosis?</H3></DIV><DIV class="back"><P>This is a &quot;simple&quot; missense mutation, leading to the loss of single amino acid, causing Cystic Fibrosis - a largely researched lethal genetic disease, found in every ethnic group world-wide.</P></DIV></DIV></DIV><DIV class="flip-container" ontouchstart="this.classList.toggle('hover');"><DIV class="flipper"><DIV class="front"><H3><SPAN>Why now</SPAN> of all times?</H3></DIV><DIV class="back"><P>Only recently has genome editing become an affordable and practical tool for <STRONG>all researchers</STRONG>, to maximize efficiency in correcting diseases causing mutations.</P></DIV></DIV></DIV><DIV class="flip-container" ontouchstart="this.classList.toggle('hover');"><DIV class="flipper"><DIV class="front"><H3><SPAN>How</SPAN> can we do it?</H3></DIV><DIV class="back"><P>Utilizing the Cholera toxin's non-toxic B Sub-unit as a delivery system for a plasmid containing a CRISPR/Cas9 apparatus, so as to specifically correct the defected DNA fragment with minimal collateral damage.</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>